Filing Details

Accession Number:
0001209191-21-007884
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-02-04 18:47:53
Reporting Period:
2021-02-02
Accepted Time:
2021-02-04 18:47:53
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1308547 Dolby Laboratories Inc. DLB () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1214091 Avadis Tevanian C/O Dolby Laboratories, Inc.
1275 Market Street
San Francisco CA 94103
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Class A Common Stock Acquisiton 2021-02-02 2,661 $0.00 2,661 No 4 A Direct
Class A Common Stock Disposition 2021-02-02 1,814 $90.00 50,561 No 4 S Indirect By Avadis Tevanian Jr. and Nancy Tevanian Trust u/a/d May 29 1996
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 S Indirect By Avadis Tevanian Jr. and Nancy Tevanian Trust u/a/d May 29 1996
Footnotes
  1. Award represents a total of 2,661 restricted stock units granted under the terms of the Issuer's 2020 Stock Plan. Each unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon vesting, which will occur on the earlier of (i) the first anniversary of the date of grant or (ii) the date immediately preceding the date of Issuer's 2022 annual meeting of stockholders, provided that, in either case, the Reporting Person continues to serve as a member of the Issuer's board of directors on such date.
  2. Shares held following the reported transactions include 2,661 restricted stock units, which are subject to forfeiture until they vest.